Covid-19 roundup: FDA commissioners call for more ‘concerted effort’ on convalescent plasma R&D; Regeneron boosts case for antibody cocktail with new animal data

Jason Mast

Editor

Amber Tong

Four former FDA commissioners have coalesced around a century-old treatment they believe can give the best weapon against Covid-19: Convalescent plasma.

Writing in

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: FDA commissioners call for more ‘concerted effort’ on convalescent plasma R&D; Regeneron boosts case for antibody cocktail with new animal data

Jason Mast

Editor

Amber Tong

Sign up to read this article for free.

Three drugmakers sue US over 340B discounts to STD clinics they allege don’t qualify

CMS explains what went into its first round of drug price negotiations

Deerfield wins fight to acquire Singular Genomics, beating out Tang Capital’s Concentra

FDA approves Lilly's Zepbound for sleep apnea, likely cracking open Medicare market

CagriSema’s weight loss data disappointed. What does Novo do next?

Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warnings

Covid-19 roundup: FDA com­mis­sion­ers call for more ‘con­cert­ed ef­fort’ on con­va­les­cent plas­ma R&D; Re­gen­eron boosts case for an­ti­body cock­tail with new an­i­mal da­ta

Editor

Sign up to read this article for free.

more like this

Covid-19 roundup: FDA commissioners call for more ‘concerted effort’ on convalescent plasma R&D; Regeneron boosts case for antibody cocktail with new animal data